OMEPRAZOLE EXTENDED-RELEASE CAPSULES
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded a delivery order under contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, identified by CAGE code 1UNB0, for the procurement of OMEPRAZOLE EXTENDED-RELEASE CAPSULES with NSN 6505013142716. The award was issued on July 24, 2026, with a total contract value of $1,133.60. The order falls under the broader procurement structure managed by the Department of Defense and is classified as a federal acquisition. The medication is intended for military and federal medical use, though specific delivery details and performance locations are not specified. The contract was posted on the DIBBS system and is accessible through the provided UI link, with no set-aside provisions or NAICS code designated for this particular solicitation.
General Info
Agency
Contract Value
$1,133.6NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
